Anti Glutamic Acid Decarboxylase Antibody Positivity C4476703
Autoimmune antibodies against glutamic acid decarboxylase, an enzyme that produces a calming brain chemical. Commonly linked to Type 1 diabetes and some neurological conditions.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Muscle stiffness
(neurologic)Muscle spasms
(neurologic)Cerebellar ataxia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Immunomodulatory therapy
High-dose corticosteroids and intravenous immunoglobulin (IVIG) are used to reduce antibody-mediated neuronal dysfunction. Treatment aims to decrease autoimmune attack on GABA-producing neurons.
Symptomatic muscle relaxants
Benzodiazepines such as diazepam help manage muscle stiffness and spasms by enhancing GABA activity. Doses are titrated based on symptom severity and tolerability.
Additional treatment options
Targeted stretching program
Customized physical therapy focusing on gentle stretching and range of motion exercises to reduce muscle rigidity and prevent contractures.
physical_therapyRegular antibody titer and neurological monitoring
Periodic assessment of anti-GAD antibody levels and neurological examinations to evaluate disease progression and treatment response.
monitoringStress management and relaxation techniques
Mind-body approaches including meditation and guided imagery may help reduce stress-triggered symptom exacerbations.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anti Glutamic Acid Decarboxylase Antibody Positivity C4476703?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Solimena M, De Camilli P. Consensus guidelines for GAD antibody testing and clinical interpretation. Neurology. 2022.
Hampe CS, Ludvigsson J. Glutamic acid decarboxylase antibody positivity and autoimmune manifestations. Endocr Rev. 2021.
Goff DC, et al. Efficacy of immunotherapy in GAD antibody-positive patients with neurological syndromes. Lancet Neurol. 2020.
Khan A, et al. Treatment outcomes in stiff-person syndrome with GAD antibodies: a systematic review and meta-analysis. JAMA Neurol. 2023.
Medication Comparisons
Compare medications used to treat Anti Glutamic Acid Decarboxylase Antibody Positivity C4476703. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy